No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
1 | general cells |
IFO50376 |
MSS62 |
mouse |
spleen |
spleen stromal cell line, (C57BL/6 mouse) |
|
2 | general cells |
IFO50378 |
FLS5 |
mouse |
liver |
Mouse liver stromal cell line. |
|
3 | general cells |
IFO50424 |
AP-16 |
mouse |
brain, astrocyte-progenitor cell |
Astrocyte differentiation is induced by TGF-beta, LIF, CNTF and serum The deprivation of EGF induces death of AP-16 cells by apoptosis. |
|
4 | general cells |
IFO50476 |
NKM-1 |
human |
peripheral blood |
leukemia, acute myeloid, myeloid leukemia cells, responsive to G-CSF and M-CSF for growth |
|
5 | general cells |
IFO50513 |
MTA |
human |
peripheral blasts |
leukemia, NK-like T cell line |
|
6 | general cells |
IFO50519 |
A1 |
mouse |
brain |
derives from p53-deficient mouse brain, used for preparation of conditioned medium for MG5 cells |
|
7 | general cells |
JCRB0156 |
KHYG-1 |
human |
peripheral blood |
Human natural killer cell line with a p53 point mutation as a model for p53-associated leukemogenesis and a model for differentiation of NK/T cells. |
|
8 | general cells |
JCRB0158.1 |
MY-M12 |
human |
peripheral blood |
Subclone of the MY, human bone marrow mononuclear cells. |
|
9 | general cells |
JCRB0197 |
OSC-20 |
human |
tongue |
Human squamous cell carcinoma cell line from tongue metastasized to neck lymph node(left), which was cultured with serum free condition. |
|
10 | general cells |
JCRB0239 |
TCO-1 |
human |
thyroid gland |
non differentiated cancer |
|
11 | general cells |
JCRB0249 |
FAA-HTC1 |
rat |
liver |
hepatocellular carcinoma, 2-acetylaminofluorene induced, (F344/DuCrj rat) |
|
12 | general cells |
JCRB0415 |
RLN-10 |
rat |
liver |
normal liver, (Donryu rat) |
|
13 | general cells |
JCRB0543 |
TIG-110 |
human |
skin |
Normal diploid fibroblast from human skin with limited lifespan. |
|
14 | general cells |
JCRB1006.2F |
OUMS-36T-2F |
human |
embryo |
fibroblast, immortalized by hTRT, derivative of OUMS-36 |
|
15 | general cells |
JCRB1010 |
KMRC-1 |
human |
kidney |
Human tumor cell line from kidney. Clear cell renal carcinoma cell line. |
|
16 | general cells |
JCRB1051 |
OUMS-24/P6X |
human |
embryo |
Human normal cells immortalized by pCDM8-p53 and X-ray irradiation. |
|
17 | general cells |
JCRB1073 |
ASH-3 |
human |
cervical tissue |
Tumor cell line with multidrug registance obtained from rapidly growing cervical tumor(neck) diagnosed as an anaplastic thyroid carcinoma. |
|
18 | general cells |
JCRB1122 |
HEC-151 |
human |
uterine corpus |
Human endometrioid adenocarcinoma, G2. |
|
19 | immortalized mesenchymal stem cell |
JCRB1136.01 |
U3-DT |
human |
bone marrow |
Human bone marrow-derived mesenchymal stem cells (long term culture (PDLs=252)). |
|
20 | general cells |
JCRB1153 |
HCA-1 |
human |
lymph node metastasis |
Human endocervical adenocarcinoma cell line. |
|
21 | general cells |
JCRB1193 |
HEC-1-B |
human |
uterine corpus |
Endometrioid adenocarcinoma (G2) from human uterus body. |
|
22 | general cells |
JCRB1213.3 |
DIG104.10H.1 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against digoxin. |
|
23 | general cells |
JCRB1222.07 |
HGH1.8.1 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). |
|
24 | general cells |
JCRB1316.3 |
OHP138.H8.1 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone. |
|
25 | general cells |
JCRB1322 |
m5S |
mouse |
Skin |
Near-diproid mouse embryonic cell line. |
|
26 | general cells |
JCRB1334 |
RC-K8 |
human |
chylous peritoneal effusion |
A human lymphoma cell line with t(11;14) chromosome abnormality. |
|
27 | general cells |
JCRB1347 |
KML-1 |
human |
pleural effusion |
Human B-cell lymphoma cell line. |
|
28 | general cells |
JCRB1548 |
H-1A(H123) |
mouse |
bone marrow |
Mouse bone marrow-derived osteoblast-like cell line. |
|
29 | genetically-modified cells |
JCRB1612 |
HuS-L12/10 |
human |
Lung |
Human immortalized cell line derived from MRC-5 cells. |
|
30 | luciferase-expressing cancer cells |
JCRB1638 |
JHH-5-Luc |
human |
resected liver sample |
Luciferase stably expressing cell line (JHH-5; Human hepatocellular carcinoma (Ed.I) established from small liver cancer). |
|
31 | general cells |
JCRB1792 |
KU-Lu-MPPt3 |
human |
|
Human lung adenocarcinoma cell line with a micropapillary pattern. |
|
32 | general cells |
JCRB1810 |
MOLM-13 |
human |
|
Human acute monocytic leukemia (AML-M5a) cell line. MOLM-13 was established from the same donor as MOLM-14. |
|
33 | general cells |
JCRB1857 |
OCUT-4 |
human |
thyroid |
human anaplastic thyroid cancer cell line |
|
34 | genetically-modified cells |
JCRB1976 |
MDCK-dTGFalpha-EKARrEV-NLS |
dog |
kidney |
Transforming growth factor alpha (TGFalpha)-deficient MDCK cell line expressing FRET biosensor EKARrEV-NLS. |
|
35 | general cells |
JCRB1998 |
KE-24 |
human |
primary colonic carcinoma |
poorly differentiated adenocarcinoma (signet-ring cell type) established from primary tumor.
|
|
36 | general cells |
JCRB2202 |
A9(Neo2) |
human chromosome-introduced |
skin |
contains human chromosome # 2 (MTA with Tottori Univ. is required.) |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.